BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen J, Wang Y, Wu XJ, Li J, Hou FQ, Wang GQ. Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B. World J Gastroenterol 2010; 16(48): 6145-6150 [PMID: 21182232 DOI: 10.3748/wjg.v16.i48.6145]
URL: https://www.wjgnet.com/1007-9327/full/v16/i48/6145.htm
Number Citing Articles
1
Qirong Li, Baozhen Sun, Yue Zhuo, Ziping Jiang, Rong Li, Chao Lin, Ye Jin, Yongjian Gao, Dongxu Wang. Interferon and interferon-stimulated genes in HBV treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1034968
2
Yudan Fu, Yi Wang, Jiqi Ouyang, Wenliang Lv. Regulatory T-cell remodeling across the HBV infection–cirrhosis continuum. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1905693
3
X.‐R. Sun, J. Wu, K.‐F. Tang. The interferon‐gamma (IFN‐γ) +874T allele reduces the risk of hepatitis B infection in an Asian population. Journal of Viral Hepatitis 2014; 21(4) doi: 10.1111/jvh.12140
4
Shihong Zhong, Qiong Li, Chunhua Wen, Yifan Li, Yang Zhou, Zihan Jin, Guofu Ye, Yanda Zhao, Jinlin Hou, Yongyin Li, Libo Tang. Interferon α facilitates anti-HBV cellular immune response in a B cell-dependent manner. Antiviral Research 2022; 207 doi: 10.1016/j.antiviral.2022.105420
5
Asha Ashuo, Jia Liu, Zhenghong Yuan, Jieliang Chen. Interferon-α for Immune Modulation in Chronic Hepatitis B Toward Functional Cure. Viruses 2025; 17(10) doi: 10.3390/v17101358
6
Prakriti Sinha, Parul Sahu. Dynamics of Immune Activation in Viral Diseases. 2020;  doi: 10.1007/978-981-15-1045-8_14
7
Siqi Peng, Huizhen Wang, Zhengtao Wang, Qingzhong Wang. Progression of Antiviral Agents Targeting Viral Polymerases. Molecules 2022; 27(21) doi: 10.3390/molecules27217370
8
Iman Ibrahim Salama, Samia M Sami, Somaia I Salama, Ghada A Abdel-Latif, Fatma A Shaaban, Walaa A Fouad, Aida M Abdelmohsen, Hala M Raslan. Current and novel modalities for management of chronic hepatitis B infection. World Journal of Hepatology 2023; 15(5): 585-608 doi: 10.4254/wjh.v15.i5.585
9
Lu Ning, Xuan Huang, Ying Xu, Guifeng Yang, Juncheng Yang, Qunfang Fu, Qi Zhang, Hai Liu, Xiaoting Wu, Zhanhui Wang, Kangxian Luo. Boosting of Hepatitis B Virus-Specific T Cell Responses After Pegylated-Interferon-α-2a Therapy for Hepatitis B e Antigen-Positive Pediatric Patients. Journal of Interferon & Cytokine Research 2019; 39(12) doi: 10.1089/jir.2019.0042
10
F.‐Q. Hou, X.‐J. Wu, Y. Wang, J. Chen, Y.‐Z. Liu, Y.‐Y. Ren, G. Song, Y.‐P. Ding, M. Yu, G.‐Q. Wang. Rapid downregulation of programmed death‐1 and interferon‐γ‐inducible protein‐10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B. Journal of Viral Hepatitis 2013; 20(s1) doi: 10.1111/jvh.12060
11
Xiao-Yan Jiang, Bing Huang, Dan-Ping Huang, Chun-Shan Wei, Wei-Chao Zhong, De-Ti Peng, Fu-Rong Huang, Guang-Dong Tong. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy. World Journal of Gastroenterology 2021; 27(11): 1101-1116 doi: 10.3748/wjg.v27.i11.1101
12
Soeradj Harkisoen, Steven Kroon, Karel J van Erpecum, Andy IM Hoepelman, Debbie van Baarle, Joop E Arends. The Influences of Antiviral Therapy on T-cell Function in Adult Patients with Chronic Hepatitis B. Future Virology 2014; 9(10) doi: 10.2217/fvl.14.76
13
Béatrice Laupèze, Ventzislav Vassilev, Selim Badur. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments. Expert Review of Gastroenterology & Hepatology 2023; 17(11) doi: 10.1080/17474124.2023.2268503
14
15
Antonia Mourtzikou, Maria Alepaki, Marilena Stamouli, Abraham Pouliakis, Anastasios Skliris, Petros Karakitsos. Evaluation of serum levels of IL-6, TNF-α, IL-10, IL-2 and IL-4 in patients with chronic hepatitis. Inmunología 2014; 33(2) doi: 10.1016/j.inmuno.2014.01.001
16
Yong Zhe Liu, Feng Qin Hou, Peng Ding, Yuan Yuan Ren, Shi Hong Li, Gui Qiang Wang. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-274
17
Walid Ben Selma, Ahmed Baligh Laribi, Sana Alibi, Jalel Boukadida. Association of an IFN-γ variant with susceptibility to chronic hepatitis B by the enhancement of HBV DNA replication. Cytokine 2021; 143 doi: 10.1016/j.cyto.2021.155525
18
Kai Yang, Shihe Guan, Hao Zhang, Zhiwu Chen. Induction of interleukin 6 impairs the anti‐HBV efficiency of IFN‐α in human hepatocytes through upregulation of SOCS3. Journal of Medical Virology 2019; 91(5) doi: 10.1002/jmv.25382
19
Li Wang, Hongjiao Chen, Yuanqi Yang, Ying Huang, Weixian Chen, Di Mu. Optimization of culture conditions for HBV-specific T cell expansion in vitro from chronically infected patients. BMC Biotechnology 2024; 24(1) doi: 10.1186/s12896-024-00908-8
20